Questions? +1 (202) 335-3939 Login
Trusted News Since 1995
A service for medical industry professionals · Friday, March 29, 2024 · 699,687,987 Articles · 3+ Million Readers

Report: Exploring Fundamental Drivers Behind Infinity Pharmaceuticals, AxoGen, MUELLER WATER PRODUCTS, MYR Group, RealNetworks, and Odonate Therapeutics — New Horizons, Emerging Trends, and Upcoming Developments

NEW YORK, Oct. 17, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Infinity Pharmaceuticals, Inc. (NASDAQ:INFI), AxoGen, Inc. (NASDAQ:AXGN), MUELLER WATER PRODUCTS (NYSE:MWA), MYR Group, Inc. (NASDAQ:MYRG), RealNetworks, Inc. (NASDAQ:RNWK), and Odonate Therapeutics, Inc. (NASDAQ:ODT), including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.

Complimentary Access: Research Reports

Full copies of recently published reports are available to readers at the links below.

INFI DOWNLOAD: http://Fundamental-Markets.com/register/?so=INFI
AXGN DOWNLOAD: http://Fundamental-Markets.com/register/?so=AXGN
MWA DOWNLOAD: http://Fundamental-Markets.com/register/?so=MWA
MYRG DOWNLOAD: http://Fundamental-Markets.com/register/?so=MYRG
RNWK DOWNLOAD: http://Fundamental-Markets.com/register/?so=RNWK
ODT DOWNLOAD: http://Fundamental-Markets.com/register/?so=ODT

(You may have to copy and paste the link into your browser and hit the [ENTER] key)

The new research reports from Fundamental Markets, available for free download at the links above, examine Infinity Pharmaceuticals, Inc. (NASDAQ:INFI), AxoGen, Inc. (NASDAQ:AXGN), MUELLER WATER PRODUCTS (NYSE:MWA), MYR Group, Inc. (NASDAQ:MYRG), RealNetworks, Inc. (NASDAQ:RNWK), and Odonate Therapeutics, Inc. (NASDAQ:ODT) on a fundamental level and outlines the overall demand for their products and services in addition to an in-depth review of the business strategy, management discussion, and overall direction going forward. Several excerpts from the recently released reports are available to today's readers below.

-----------------------------------------

Important Notice: the following excerpts are not designed to be standalone summaries and as such, important information may be missing from these samples. Please download the entire research report, free of charge, to ensure you are reading all relevant material information. All information in this release was accessed October 15th, 2018. Percentage calculations are performed after rounding. All amounts in millions (MM), except per share amounts.

-----------------------------------------

INFINITY PHARMACEUTICALS, INC. (INFI) REPORT OVERVIEW

Infinity Pharmaceuticals' Recent Financial Performance

For the twelve months ended December 31st, 2017 vs December 31st, 2016, Infinity Pharmaceuticals reported revenue of $6.00MM vs $18.72MM (down 67.95%) and analysts estimated basic earnings per share -$0.83 vs -$0.61. Analysts expect earnings to be released on November 6th, 2018. The report will be for the fiscal period ending September 30th, 2018. The reported EPS for the same quarter last year was -$0.14. The estimated EPS forecast for the next fiscal year is -$0.50 and is expected to report on March 21st, 2019.

To read the full Infinity Pharmaceuticals, Inc. (INFI) report, download it here: http://Fundamental-Markets.com/register/?so=INFI

-----------------------------------------

AXOGEN, INC. (AXGN) REPORT OVERVIEW

AxoGen's Recent Financial Performance

For the three months ended June 30th, 2018 vs June 30th, 2017, AxoGen reported revenue of $20.58MM vs $15.17MM (up 35.71%) and analysts estimated basic earnings per share -$0.20 vs -$0.06. For the twelve months ended December 31st, 2017 vs December 31st, 2016, AxoGen reported revenue of $60.43MM vs $41.11MM (up 47.00%) and analysts estimated basic earnings per share -$0.31 vs -$0.47. Analysts expect earnings to be released on November 7th, 2018. The report will be for the fiscal period ending September 30th, 2018. Reported EPS for the same quarter last year was -$0.06. The estimated EPS forecast for the next fiscal year is -$0.32 and is expected to report on February 27th, 2019.

To read the full AxoGen, Inc. (AXGN) report, download it here: http://Fundamental-Markets.com/register/?so=AXGN

-----------------------------------------

MUELLER WATER PRODUCTS (MWA) REPORT OVERVIEW

MUELLER WATER PRODUCTS's Recent Financial Performance

For the three months ended June 30th, 2018 vs June 30th, 2017, MUELLER WATER PRODUCTS reported revenue of $250.20MM vs $232.20MM (up 7.75%) and analysts estimated basic earnings per share $0.10 vs $0.15 (down 33.33%). For the twelve months ended September 30th, 2017 vs September 30th, 2016, MUELLER WATER PRODUCTS reported revenue of $826.00MM vs $800.60MM (up 3.17%) and analysts estimated basic earnings per share $0.77 vs $0.40 (up 92.50%). Analysts expect earnings to be released on November 7th, 2018. The report will be for the fiscal period ending September 30th, 2018. Reported EPS for the same quarter last year was $0.15. The estimated EPS forecast for the next fiscal year is $0.64 and is expected to report on November 7th, 2018.

To read the full MUELLER WATER PRODUCTS (MWA) report, download it here: http://Fundamental-Markets.com/register/?so=MWA

-----------------------------------------

MYR GROUP, INC. (MYRG) REPORT OVERVIEW

MYR Group's Recent Financial Performance

For the three months ended June 30th, 2018 vs June 30th, 2017, MYR Group reported revenue of $339.68MM vs $356.19MM (down 4.63%) and basic earnings per share $0.42 vs $0.08 (up 425.00%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, MYR Group reported revenue of $1,403.32MM vs $1,142.49MM (up 22.83%) and analysts estimated basic earnings per share $1.30 vs $1.25 (up 4.00%). Analysts expect earnings to be released on November 7th, 2018. The report will be for the fiscal period ending September 30th, 2018. The reported EPS for the same quarter last year was $0.31. The estimated EPS forecast for the next fiscal year is $2.34 and is expected to report on March 6th, 2019.

To read the full MYR Group, Inc. (MYRG) report, download it here: http://Fundamental-Markets.com/register/?so=MYRG

-----------------------------------------

REALNETWORKS, INC. (RNWK) REPORT OVERVIEW

RealNetworks' Recent Financial Performance

For the three months ended June 30th, 2018 vs June 30th, 2017, RealNetworks reported revenue of $15.72MM vs $21.61MM (down 27.22%) and analysts estimated basic earnings per share -$0.18 vs -$0.09. For the twelve months ended December 31st, 2017 vs December 31st, 2016, RealNetworks reported revenue of $78.72MM vs $81.48MM (down 3.39%) and analysts estimated basic earnings per share -$0.44 vs -$0.99. Analysts expect earnings to be released on November 7th, 2018. The report will be for the fiscal period ending September 30th, 2018.

To read the full RealNetworks, Inc. (RNWK) report, download it here: http://Fundamental-Markets.com/register/?so=RNWK

-----------------------------------------

ODONATE THERAPEUTICS, INC. (ODT) REPORT OVERVIEW

Odonate Therapeutics' Recent Financial Performance

Analysts expect earnings to be released on October 29th, 2018. The report will be for the fiscal period ending September 30th, 2018. The estimated EPS forecast for the next fiscal year is -$3.38 and is expected to report on February 13th, 2019.

To read the full Odonate Therapeutics, Inc. (ODT) report, download it here: http://Fundamental-Markets.com/register/?so=ODT

-----------------------------------------

ABOUT FUNDAMENTAL MARKETS

Fundamental Markets serves thousands of members and have provided research through some of the world's leading brokerages for over a decade–and continue to be one of the best information sources for investors and investment professionals worldwide. Fundamental Markets' roster boasts decades of financial experience and includes top financial writers, FINRA® BrokerCheck® certified professionals with current and valid CRD® number designations, as well as Chartered Financial Analyst® (CFA®) designation holders, to ensure up to date factual information for active readers on the topics they care about.

REGISTERED MEMBER STATUS

Fundamental Markets' oversight and audit staff are registered analysts, brokers, and/or financial advisers ("Registered Members") working within Equity Research, Media, and Compliance departments. Fundamental Markets' roster includes qualified CFA® charterholders, licensed securities attorneys, and registered FINRA® members holding duly issued CRD® numbers. Current licensed status of several Registered Members at Fundamental Markets have been independently verified by an outside audit firm, including policy and audit records duly executed by Registered Members. Complaints, concerns, questions, or inquiries regarding this release should be directed to Fundamental Markets' Compliance department by Phone, at +1 667-401-0010, or by E-mail at compliance@Fundamental-Markets.com.

LEGAL NOTICES

Information contained herein is not an offer or solicitation to buy, hold, or sell any security. Fundamental Markets, Fundamental Markets members, and/or Fundamental Markets affiliates are not responsible for any gains or losses that result from the opinions expressed. Fundamental Markets makes no representations as to the completeness, accuracy, or timeliness of the material provided and all materials are subject to change without notice. Fundamental Markets has not been compensated for the publication of this press release by any of the above mentioned companies. Fundamental Markets is not a financial advisory firm, investment adviser, or broker-dealer, and does not undertake any activities that would require such registration. For our full disclaimer, disclosure, and terms of service please visit our website.

Media Contact:
Andrew Duffie, Media Department
Office: +1 667-401-0010
E-mail: media@Fundamental-Markets.com

© 2018 Fundamental Markets. All Rights Reserved. For republishing permissions, please contact a partner network manager at partnership@Fundamental-Markets.com.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

FINRA®, BrokerCheck®, and CRD® are registered trademarks owned by Financial Industry Regulatory Authority, Inc.

Powered by EIN News


EIN Presswire does not exercise editorial control over third-party content provided, uploaded, published, or distributed by users of EIN Presswire. We are a distributor, not a publisher, of 3rd party content. Such content may contain the views, opinions, statements, offers, and other material of the respective users, suppliers, participants, or authors.

Submit your press release